Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

51 - 60 of 935 results found

Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373)

Date
Sunday, March 17, 2024 - 4:00 AM
Description
A benefit-risk assessment of NVX-CoV2373, a vaccine to prevent COVID-19, was conducted to determine if the benefits of vaccination outweigh the risks of myocarditis/pericarditis. This analysis used data on myocarditis/pericarditis cases observed in